This company manufactures biological reagents, including recombinant proteins, monoclonal antibodies, and other research reagents, for life science research, clinical research, and clinical diagnostics. Their products are used for the immunological detection of infectious diseases and other analytes.
Funding
Funding not disclosed
Founders
Product
Problem
Life science researchers and diagnostic companies require reliable and consistent biological reagents for research, development, and manufacturing. The production of high-quality recombinant proteins and antibodies can be technically challenging and expensive, particularly for specialized applications.
Solution
DevaTal, Inc. manufactures and supplies a range of biological reagents, including recombinant proteins and monoclonal antibodies, to support basic research, clinical research, and clinical diagnostics. The company leverages its expertise in protein production and antibody development to offer a diverse catalog of products, including cytokines, chemokines, viral antigens, and antibodies targeting infectious diseases. DevaTal utilizes both direct and indirect sales, including strategic alliances, to distribute its products. They also engage in R&D contracts, providing technology and know-how for large-scale recombinant protein production, with relationships based on OEM, royalties, and profit-sharing agreements.
Target Audience
DevaTal's primary customers include life science researchers in academia and industry, clinical research organizations, and diagnostic companies developing assays for infectious diseases and other analytes.
Features
- Recombinant proteins, including cytokines, chemokines, growth factors, hormones, and viral antigens
- Monoclonal and polyclonal antibodies for various research and diagnostic applications
- Products for immunological detection of infectious diseases, including HIV, HTLV, hepatitis, CMV, EBV, and SARS-CoV-2
- Custom antibody development and recombinant protein production services
- Capabilities for large-scale production of recombinant proteins
- Colloidal gold and fluorescence detection techniques for rapid diagnostic test development